Published in Infection on December 05, 1996
Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection. PLoS One (2012) 2.01
Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J Clin Microbiol (1997) 1.83
Distribution of Borrelia burgdorferi sensu lato genomic groups in Europe, a review. Eur J Epidemiol (1997) 1.56
In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto. J Clin Microbiol (2003) 0.99
Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know. Wien Klin Wochenschr (2006) 0.95
Efficacy of short-course ceftriaxone therapy for Borrelia burgdorferi infection in C3H mice. Antimicrob Agents Chemother (2002) 0.94
Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability. J Clin Microbiol (2012) 0.87
Persister Development by Borrelia burgdorferi Populations In Vitro. Antimicrob Agents Chemother (2015) 0.85
Severe course of Lyme neuroborreliosis in an HIV-1 positive patient; case report and review of the literature. BMC Neurol (2010) 0.81
Pharmacokinetic analysis of oral doxycycline in rhesus macaques. J Med Primatol (2012) 0.75
Cooperation of Doxycycline with Phytochemicals and Micronutrients Against Active and Persistent Forms of Borrelia sp. Int J Biol Sci (2016) 0.75
In vitro susceptibility of Borrelia burgdorferi isolates to three antibiotics commonly used for treating equine Lyme disease. BMC Vet Res (2017) 0.75
The lymphocyte transformation test for the diagnosis of Lyme borreliosis has currently not been shown to be clinically useful. Clin Microbiol Infect (2014) 2.62
Detection of Borrelia burgdorferi in patients with Lyme disease by the polymerase chain reaction. J Clin Pathol (1991) 2.23
Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrob Agents Chemother (1996) 1.83
Molecular mimicry and Lyme borreliosis: a shared antigenic determinant between Borrelia burgdorferi and human tissue. Ann Neurol (1989) 1.83
Epidemiology of European Lyme borreliosis. Zentralbl Bakteriol (1998) 1.59
Borrelia burgdorferi and different types of morphea. Dermatologica (1991) 1.47
Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens. J Clin Microbiol (2001) 1.46
Clinical outcome of Borrelia burgdorferi related dilated cardiomyopathy after antibiotic treatment. Lancet (1992) 1.42
Differential expression of tumor necrosis factor receptor subtypes on leukocytes in systemic inflammatory response syndrome. Crit Care Med (1999) 1.40
Borrelia infection as a possible cause of HLA-B27 negative sacroiliitis. J Rheumatol (1991) 1.38
Comparison of different antigen preparations in an evaluation of the immune response to Campylobacter pylori. Eur J Clin Microbiol Infect Dis (1988) 1.37
Differences between Lyme disease and European arthropod-borne Borrelia infections. Lancet (1985) 1.32
Polyneuritis cranialis associated with Borrelia burgdorferi. J Neurol Neurosurg Psychiatry (1985) 1.18
A European multicenter study of immunoblotting in serodiagnosis of lyme borreliosis. J Clin Microbiol (2000) 1.17
Identification of Borrelia burgdorferi sensu lato species in Europe. Zentralbl Bakteriol (1998) 1.12
Evaluating frequency, diagnostic quality, and cost of Lyme borreliosis testing in Germany: a retrospective model analysis. Clin Dev Immunol (2011) 1.08
[Comparison of the ELISA (lipopolysaccharide) and Widal reactions (O antigen) in the diagnosis of Salmonella infections]. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 1.06
The efficacy of antimicrobial treatment in Campylobacter pylori-associated gastritis and duodenal ulcer. Scand J Gastroenterol Suppl (1988) 1.05
Indirect immunofluorescence assay (IFA), microagglutination test (MA) and enzyme-linked-immunosorbent assay (ELISA) in diagnosis of legionellosis. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 1.03
Histological evidence for spirochetal origin of morphea and lichen sclerosus et atrophicans. Am J Dermatopathol (1987) 1.03
Comparison of SeroMP IgA with four other commercial assays for serodiagnosis of Mycoplasma pneumoniae pneumonia. Diagn Microbiol Infect Dis (2001) 1.00
[Double infection with early summer meningoencephalitis virus and Borrelia burgdorferi]. Dtsch Med Wochenschr (1986) 1.00
[Campylobacter pylori, gastritis and peptic ulcer]. Wien Klin Wochenschr (1987) 0.96
Lyme disease in a 74-year-old forest owner with symptoms of dermatomyositis. Arthritis Rheum (1995) 0.95
Importance of surveillance of tularemia natural foci in the known endemic area of Central Europe, 1991-1997. Wien Klin Wochenschr (2001) 0.95
Species, developmental stage and infection with microbial pathogens of engorged ticks removed from dogs and questing ticks. Med Vet Entomol (2012) 0.94
Borrelia transfer by ticks during their life cycle. Studies on laboratory animals. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 0.93
Isolation and polymerase chain reaction typing of Borrelia afzelii from a skin lesion in a seronegative patient with generalized ulcerating bullous lichen sclerosus et atrophicus. Br J Dermatol (2001) 0.93
Is localised scleroderma a Borrelia infection? Lancet (1985) 0.92
Neuroborreliosis in morphea and lichen sclerosus et atrophicus. J Am Acad Dermatol (1988) 0.90
Solitary borrelial lymphocytoma: report of 36 cases. Infection (1992) 0.90
Effectiveness of cefamandole against methicillin-resistant strains of Staphylococcus aureus in vitro and in experimental infections. J Antimicrob Chemother (1984) 0.90
Lymphoproliferative responses to Borrelia burgdorferi in circumscribed scleroderma. Br J Dermatol (1996) 0.90
The European Union Concerted Action World Wide Web site for Lyme borreliosis. Zentralbl Bakteriol (1998) 0.90
Borrelia burgdorferi antibodies in patients with relapsing/remitting form and chronic progressive form of multiple sclerosis. J Neurol Neurosurg Psychiatry (1988) 0.89
Does Lyme borreliosis also occur in tropical and subtropical areas? Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.89
Evidence for spirochetal origin of circumscribed scleroderma (morphea). Acta Derm Venereol (1987) 0.88
Epidemiology of borrelia infections in Austria. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.87
Infections following tickbites. Tick-borne encephalitis and Lyme borreliosis--a prospective epidemiological study from Tyrol. Infection (1989) 0.87
[Investigations on the immune response against meningococcal polysaccharide in children (author's transl)]. Immun Infekt (1980) 0.87
Lyme borreliosis and multiple sclerosis. Lancet (1987) 0.86
Characterization of the first tick isolate of Borrelia burgdorferi from Italy. APMIS (1989) 0.86
Reactivity of neuroborreliosis patients (Lyme disease) to cardiolipin and gangliosides. J Neurol Sci (1993) 0.86
Possible causes of symptoms in suspected coronary heart disease but normal angiograms. Clin Cardiol (2001) 0.85
The role of Chlamydia pneumoniae in human aortic disease-a hypothesis revisited. Eur J Vasc Endovasc Surg (2004) 0.84
Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children--a prospective study. Infection (1991) 0.84
Occurrence, serotypes and biotypes of thermophilic Campylobacters isolated in Vienna. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.84
Isolation of Borrelia afzelii from circumscribed scleroderma. Br J Dermatol (1999) 0.84
[Lymphocyte proliferation test in cutaneous manifestations of Lyme borreliosis]. Wien Med Wochenschr (1995) 0.83
Evidence for spirochetal origin of Sudeck's atrophy (algodystrophy, reflex sympathetic dystrophy). Arch Orthop Trauma Surg (1989) 0.83
Detection of spotted fever group (SFG) rickettsia in Ixodes ricinus ticks in Austria. Acta Virol (1997) 0.83
Shulman syndrome, a scleroderma subtype caused by Borrelia burgdorferi? Lancet (1987) 0.82
Chronic forms of Borrelia burgdorferi infection of the nervous system. Neurology (1987) 0.82
Lyme borreliosis of central nervous system (CNS) in children: a diagnostic challenge. Infection (1991) 0.82
The elephant knee joint: morphological and biomechanical considerations. J Anat (2006) 0.82
Detection of Borrelia burgdorferi sensu lato in ticks: immunofluorescence assay versus polymerase chain reaction. Zentralbl Bakteriol (1998) 0.81
Specificity of CSF antibodies against components of Borrelia burgdorferi in patients with meningopolyneuritis Garin-Bujadoux-Bannwarth. J Neurol (1986) 0.81
[Yersinia enterocolitica in drinking water (author's transl)]. Zentralbl Bakteriol Mikrobiol Hyg B (1981) 0.81
[Comparison of growth of Staphylococcus aureus in a fibrin-clotting system and in clotted blood - a quantitative investigation (author's transl)]. Zentralbl Bakteriol Orig A (1978) 0.81
Anti-myelin antibodies in cerebrospinal fluid and serum of patients with meningopolyneuritis Garin-Bujadoux-Bannwarth and other neurological diseases. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 0.81
Pneumonia due to blastomyces dermatitidis in a European renal transplant recipient. Nephrol Dial Transplant (1996) 0.81
Neurological manifestations of Borrelia burgdorferi-infections: the enlarging clinical spectrum. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.80
Neuropathy associated with acrodermatitis chronica atrophicans. Clinical and morphological features. Ann N Y Acad Sci (1988) 0.80
Chronic granulomatous meningitis with multiple cranial nerve lesions hydrocephalus, stroke, sinus thrombosis, and epilepsy. South Med J (2000) 0.79
Austrian hard ticks as vectors of Borrelia burgdorferi, overview. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 0.79
Lyme borreliosis and emerging tick-borne diseases in Europe. Wien Klin Wochenschr (1998) 0.79
Sensitivity of various spiroplasma strains against ethanol, formalin, glutaraldehyde, and phenol. Zentralbl Bakteriol Mikrobiol Hyg B (1981) 0.79
In vitro properties of mixtures of fibrin seal and antibiotics. Biomaterials (1983) 0.79
Preliminary survey of Leptospirosis and Lyme disease amongst febrile patients attending community hospital ambulatory care in Maputo, Mozambique. Cent Afr J Med (1997) 0.79
Indium 111-monoclonal antimyosin antibody and magnetic resonance imaging in the diagnosis of acute Lyme myopericarditis. Arch Intern Med (1993) 0.79
Growth of various bacteria and yeast in a peptide and an element diet. J Hosp Infect (1983) 0.79
Agglutination test versus ELISA in the diagnosis of typhoid fever. Eur J Epidemiol (1988) 0.79
Lyme borreliosis as a cause of myocarditis and heart muscle disease. Eur Heart J (1991) 0.79
European interlaboratory comparison of Lyme borreliosis serology. Zentralbl Bakteriol (1998) 0.79
Cerebrospinal fluid findings in neurological manifestations of Lyme disease. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.78
Determination of meningococcal antibodies by microassay. Bull World Health Organ (1978) 0.78
[Susceptibility of the Bacteroides fragilis group to 10 antibiotics. Results of 4 laboratories in Austria]. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 0.78
High-dose penicillin therapy in meningopolyneuritis Garin-Bujadoux-Bannwarth. Clinical and cerebrospinal fluid data. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.78
Oligoclonal antibodies in CSF of patients with meningopolyneuritis Garin-Bujadoux-Bannwarth: Ig class, light chain type and specificity. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.78
Bacterial contamination of dialysate in dialysis-associated endotoxaemia. J Hosp Infect (1989) 0.77
Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis. Infection (1996) 0.77
Increase of chlamydial LPS antibodies in patients with acute coronary syndrome without detection of chlamydial DNA in atherectomy samples. Wien Klin Wochenschr (2001) 0.77
Risk assessment in Lyme borreliosis. Zentralbl Bakteriol (1998) 0.77
Immunoglobulin allotypes and immune response to meningococcal polysaccharides A and C. J Immunogenet (1982) 0.77
[Microbiological monitoring of embalmed cadavera during dissection courses (author's transl)]. Anat Anz (1979) 0.76
Reactive arthritis: urogenital swab culture is the only useful diagnostic method for the detection of the arthritogenic infection in extra-articularly asymptomatic patients with undifferentiated oligoarthritis. Br J Rheumatol (1995) 0.76
Preliminary characterization of Borrelia burgdorferi CSF isolates. Infection (1991) 0.76
[Comparison of disinfectant activity of 3 different embalming fluids on cadavera for anatomical study (author's transl)]. Anat Anz (1979) 0.76
Lyme borreliosis in children. A controlled clinical study based on ELISA values. Eur J Pediatr (1989) 0.76
European Lyme borreliosis clinical spectrum. Zentralbl Bakteriol (1998) 0.76
Success and failure in the treatment of acrodermatitis chronica atrophicans. Infection (1996) 0.76
Isolation of spirochetes from the skin of patients with erythema chronicum migrans in Austria. Zentralbl Bakteriol Mikrobiol Hyg A (1985) 0.76
Genetic approaches to cell biology and metabolism of spirochetes. Res Microbiol (1993) 0.76
HLA-DR in Lyme borreliosis. Lancet (1986) 0.76
Antibody response to somatic antigen of Salmonella typhi in areas endemic and non-endemic for typhoid fever. Infect Control (1985) 0.75
Myocarditis. N Engl J Med (2001) 0.75
[Comparison of efficacy of 14 procedures for the hygienic disinfection of hands (author's transl)]. Zentralbl Bakteriol Orig B (1977) 0.75
The prevalence of ureaplasma, mycoplasma and antibodies against chlamydia group antigen in gynecological outpatients. Arch Gynecol (1985) 0.75
[Serologic studies following cholera vaccination]. MMW Munch Med Wochenschr (1983) 0.75
Mycoplasmas: agents of human, animal, and plant infections. Wien Klin Wochenschr (1997) 0.75